显微血管减压术治疗复合与单一颅神经高兴奋综合征的预后比较
结果显示复合HDS与单一HDS在术后面肌痉挛、三叉神经痛和舌咽神经痛的预后上无显著差异,术后并发症也无显著差异,表明MVD对复合HDS同样安全有效。
要点
- 复合HDS与单一HDS在MVD术后预后无显著差异。
- 复合HDS中86.7%为异时性发病,66.7%为双侧受累。
- MVD可推荐作为复合HDS的安全有效治疗选择。
核心结论
- 复合HDS患者接受MVD术后的预后与单一HDS相似。
- MVD可推荐作为复合及单一HDS患者的安全有效治疗选择。
研究设计与样本
- 其中45例复合HDS患者接受了66次手术,通过电子病历回顾收集人口学、疾病特征和术后预后数据。
主要发现
- 复合HDS中86.7%为异时性发病,66.7%为双侧受累。
- 面肌痉挛(HFS)后出现三叉神经痛(TN)是最常见的复合类型(28.9%)。
- 复合与单一HDS在HFS、TN和舌咽神经痛的术后预后无显著差异。
- 复合HDS中,HFS和TN的术后预后在性别、手术年龄、症状持续时间、合并症和责任血管方面无差异。
- 复合与单一HDS的术后并发症无显著差异。
临床怎么用
- 对于复合HDS患者,MVD可作为安全有效的治疗选择,预后与单一HDS相似。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: Hyperactive dysfunction syndrome (HDS) of cranial nerves is caused by vascular compression of the cranial nerves and results in manifestation of specific symptoms of the involved cranial nerves. The purpose of this study was to compare the prognosis of combined and single HDS after microvascular decompression (MVD) surgery and to identify the contributing factors. METHODS: From January 2001 to December 2022, a total of 5034 patients with HDS underwent 5055 MVD surgeries, of which 45 patients with combined HDS underwent 66 surgeries. Data concerning the subjects' demographic and disease-related characteristics and postoperative prognosis were collected by reviewing electronic medical records. RESULTS: Combined HDS had metachronous onset in 86.7% of patients and bilateral involvement in 66.7%. Hemifacial spasm (HFS) followed by trigeminal neuralgia (TN) was the most common type of combined HDS (28.9%). No significant differences were observed in postoperative prognosis between combined and single HDS for HFS, TN, and glossopharyngeal neuralgia. In combined HDS, no differences were observed in postoperative prognosis according to sex, age at surgery, symptom duration, comorbidities, and offending vessels for both HFS and TN. No significant differences in postoperative complications were identified between combined and single HDS. CONCLUSIONS: The prognosis after MVD surgery for combined HDS was similar to that for single HDS. MVD can be recommended as a safe and effective treatment option for patients with combined as well as single HDS.
引用
- Lee JA, Park K, Lee S, et al. Comparison of Prognosis After Microvascular Decompression in Combined and Single Hyperactive Dysfunction Syndrome of the Cranial Nerves. World Neurosurg. 2025. PMID: 41077182. doi:10.1016/j.wneu.2025.124557
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。